Medical Devices: Page 15
-
Dexcom recalls G6 CGM app over software problem
A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to download an update.
By Elise Reuter • Nov. 4, 2025 -
Olympus further clarifies device use after serious injuries and death
The update is intended to cut the risk of endobronchial combustion that has been linked to serious injuries and one death.
By Nick Paul Taylor • Nov. 3, 2025 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineTop 5 stories from MedTech Dive
From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Edwards CFO Scott Ullem to exit post
Ullem, who has held the position for more than a decade, will transition to an advisory role after his replacement is named by mid-2026.
By Susan Kelly • Oct. 31, 2025 -
3 takeaways from TCT 2025
Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.
By Susan Kelly • Oct. 31, 2025 -
US to lower China tariffs as part of trade war truce
The truce also includes de-escalating other trade actions, such as China's rare earth export controls and U.S. investigations into China-linked ships.
By Phil Neuffer • Oct. 30, 2025 -
Philips receives FDA warning letter over quality issues
The notice follows inspections of three Philips facilities that found failures to meet standards for reporting complaints and corrective actions.
By Elise Reuter • Oct. 30, 2025 -
Zimmer wins FDA’s breakthrough status for tech to prevent joint infections
Integrating a controlled-release iodine layer into hip implants could reduce the rate of potentially fatal infections.
By Nick Paul Taylor • Oct. 30, 2025 -
Medline files for initial public offering
The medical and surgical products provider could reportedly raise $5 billion at a $50 billion valuation.
By Nick Paul Taylor • Oct. 30, 2025 -
CMS grants NCD for renal denervation, benefiting Medtronic, Recor
National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.
By Susan Kelly • Oct. 29, 2025 -
J&J partners with Nvidia on AI for kidney stone procedures
The medtech firm is using Nvidia’s technology in its Monarch robotic platform for urology.
By Elise Reuter • Oct. 28, 2025 -
Olympus execs talk about import alert, GI robot and AI
CEO Bob White and Chief Strategy Officer Gabriela Kaynor discussed the medtech company’s quality and technology priorities after a year of change.
By Elise Reuter • Oct. 28, 2025 -
Medtronic links renal denervation to 3-year blood pressure reduction
Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.
By Nick Paul Taylor • Oct. 28, 2025 -
J&J awards first grants from AI surgery fund
Mayo Clinic and QAS.AI will receive funding and mentorship to help advance their projects.
By Elise Reuter • Oct. 27, 2025 -
Profile
Corcym, CardioPrecision set sights on robotic heart valve replacement
The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the longer-term advantages of open heart surgery.
By Susan Kelly • Oct. 27, 2025 -
Accuray hires Steve La Neve as CEO in transformation effort
The radiotherapy systems maker unveiled the leadership change and strategy initiatives as it reported a preliminary fiscal first-quarter adjusted loss.
By Susan Kelly • Oct. 24, 2025 -
Medtech industry closely watching Section 232 investigation
The investigation, which could be used to impose tariffs for medical products, has raised the attention of several industry groups. Check out MedTech Dive’s roundup of coverage on the 232 probe.
By Elise Reuter • Oct. 24, 2025 -
Profile
Hemorrhage can be a serious problem after pregnancy. Here’s how one medtech founder is tackling it
Kelsey Mayo, CEO of Armor Medical, received the grand prize in MedTech Innovator’s pitch competition for a wearable technology to detect serious blood loss early.
By Elise Reuter • Oct. 23, 2025 -
Solventum hires Heather Knight from Baxter to fill new C-suite post
Chris Barry, group president of medsurg at Solventum, is leaving the company at the end of the year in connection with Knight’s arrival.
By Nick Paul Taylor • Oct. 23, 2025 -
CoMind raises $102.5M to develop non-invasive bedside brain monitor
The company is enrolling patients in an early feasibility trial as part of plans to launch its device in 2027.
By Nick Paul Taylor • Updated Oct. 28, 2025 -
Intuitive Surgical reports strong Q3 as da Vinci procedures climb
Intuitive Surgical’s shares surged nearly 15% early Wednesday after the robot maker’s third-quarter sales and earnings topped analysts’ expectations.
By Susan Kelly • Oct. 22, 2025 -
AHA urges tariff exceptions for certain PPE, medical devices
The American Hospital Association warned future tariffs arising from the Trump administration’s Section 232 investigation could disrupt access to an array of tools and personal protective equipment.
By Susan Kelly • Oct. 21, 2025 -
Hologic to go private for up to $18.3B
Funds managed by Blackstone and TPG plan to acquire the medtech firm for up to $79 per share.
By Elise Reuter • Oct. 21, 2025 -
MDMA warns Section 232 tariffs could hurt US medtech manufacturing
The trade group said levies would “needlessly disrupt a globally integrated industry that already meets domestic demand.”
By Nick Paul Taylor • Oct. 21, 2025 -
Q&A
Biolinq’s Jared Tangney on making CGMs unintimidating
The chief technology officer and co-founder explained the technology and design choices that went into Biolinq’s device, which he hopes will be easier to use than other glucose monitors.
By Elise Reuter • Oct. 20, 2025 -
Dexcom faces proposed class action suit over G7 CGM problems
The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.
By Elise Reuter • Oct. 20, 2025